Expand Document  |  Expand Chapter  |  Full TOC  |  Printable HTML version
Pharmaceuticals and the Internet Drug Regulatory Authorities' Perspective - Joint NLN-WHI Workshop, 24-25 September 2001
(2002; 80 pages) View the PDF document
Table of Contents
View the documentExecutive Summary
View the documentOverview of activities by the World Health Organization - Dr Lembit Rägo
View the documentOverview of activities by the Nordic Council on Medicines - Dr Ola Westbye
Open this folder and view contentsCountry Experiences
View the documentThe Danish Consumer Council - Ms Margrethe Nielsen
View the documentSwedish Industry Association - Dr Håkan Mandahl
View the documentIntroduction to discussion points - Dr Lembit Rägo
View the documentQuality aspects - Dr Ola Westbye
View the documentPilot study on drug regulatory web sites: Current status and future challenges - Ms Elodie Jambert
View the documentThe WHO model web site for drug regulatory authorities - Dr Lembit Rägo, Ms Elodie Jambert, Mr Jorg Hetzke
View the documentConcluding discussion
Open this folder and view contentsAnnexes
View the documentReferences
View the documentBack cover
 

Pharmaceuticals and the Internet Drug Regulatory Authorities' Perspective - Joint NLN-WHI Workshop, 24-25 September 2001

24-25 September 2001, Copenhagen, Denmark

NLN Publication Number 56

WHO Library Cataloguing-in-Publication Data

Pharmaceuticals and the internet: drug regulatory authorities’ perspective

(NLN publication; no. 56)

Jointly published by the Nordic Council on Medicines (NLN) and the World Health Organization; includes the report of the NLN Conference 2001 on Pharmaceuticals and the Internet, 24-25 September 2001, organized in collaboration with the World Health Organization.

1. Legislation, Drug 2. Internet - standards 3. Drug and narcotic control - methods I. NLN Conference on Pharmaceuticals and the Internet (2001: Copenhagen, Denmark) II. Series

ISBN 92 4 159006 8

(NLM classification: QV 33)

The World Health Organization welcomes requests for permission to reproduce or translate its publications, in part or in full. Applications and enquiries should be addressed to the Office of Publications, World Health Organization, Geneva, Switzerland, which will be glad to provide the latest information on any changes made to the text, plans for new editions, and reprints and translations already available.

© World Health Organization 2002

Publications of the World Health Organization enjoy copyright protection in accordance with the provisions of Protocol 2 of the Universal Copyright Convention. All rights reserved.

The designations employed and the presentation of the material in this publication do not imply the expression of any opinion whatsoever on the part of the Secretariat of the World Health Organization concerning the legal status of any country, territory, city or area or of its authorities, or concerning the delimitation of its frontiers or boundaries.

The mention of specific companies or of certain manufacturers’ products does not imply that they are endorsed or recommended by the World Health Organization in preference to others of a similar nature that are not mentioned. Errors and omissions excepted, the names of proprietary products are distinguished by initial capital letters.

Printed and bound in Malta by Interprint Limited

to next section
 
 
The WHO Essential Medicines and Health Products Information Portal was designed and is maintained by Human Info NGO. Last updated: March 20, 2014